Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Top Cited Papers
Open Access
- 31 July 2008
- Vol. 113 (6) , 1387-1395
- https://doi.org/10.1002/cncr.23712
Abstract
BACKGROUND. The purpose of this study was to investigate whether tumor‐infiltrating immune cells in biopsy specimens can be used to predict the clinical outcome of stage IV nonsmall cell lung cancer (NSCLC) patients. METHOD. The authors performed an immunohistochemical study to identify and count the number of CD68+ macrophages, c‐kit+ mast cells, and CD8+ T cells in both cancer nests and cancer stroma in pretreatment biopsy specimens obtained from 199 patients with stage IV NSCLC treated by chemotherapy, and then analyzed for correlations between the number of immune cells and clinical outcome, including chemotherapy response and prognosis. RESULTS. There was no correlation between the number of immune cells in either cancer nests or stroma and chemotherapy response. Patients with more tumor‐infiltrating macrophages in cancer nests than in cancer stroma (macrophages, nests > stroma) had significantly better survival than nests < stroma cases median survival time (MST 440 days vs 199 days; P < .0001). Patients with more tumor‐infiltrating CD8+ T cells in cancer nests than in cancer stroma (CD8+ T cells: nests > stroma) showed significantly better survival than in nests < stroma cases (MST 388 days vs 256 days; P = .0070). The proportion of tumor‐infiltrating macrophages or CD8+ T cells between cancer nests and stroma became independent prognostic factors in the multivariate analysis. Neither the number of mast cells in nests nor in stroma correlated with the clinical outcome. CONCLUSIONS. Evaluation of the numbers of macrophages and CD8+ T cells in cancer nests and stroma are useful biomarkers for predicting the prognosis of stage IV NSCLC patients treated with chemotherapy, but could fail to predict chemotherapy response. Cancer 2008. © 2008 American Cancer Society.Keywords
This publication has 31 references indexed in Scilit:
- Can a mast cell subtype (MCT) play a role in the progression of endometrial cancer through angiogenesis?American Journal of Obstetrics and Gynecology, 2006
- Targeting tumor-associated macrophages as a novel strategy against breast cancerJournal of Clinical Investigation, 2006
- Transfection of mouse macrophage metalloelastase gene into murine CT-26 colon cancer cells suppresses orthotopic tumor growth, angiogenesis and vascular endothelial growth factor expressionCancer Letters, 2006
- Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinomaBritish Journal of Cancer, 2006
- Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancerAmerican Journal of Obstetrics and Gynecology, 2005
- Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune responseJournal of Surgical Oncology, 2003
- Mast cells and angiogenesisAPMIS, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patientsMelanoma Research, 2000
- Roles of langerhans' cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancerCancer, 1992